The personal health implications behind rare diseases are seldom considered in widespread medical care. The low incidence rate and complex treatment process makes rare disease research an underrated field in the life sciences. However, it is in these particular conditions that the strongest relations between genotypes and phenotypes are identified. The rare disease patient manager, detailed in this manuscript, presents an innovative perspective for a patient-centric portal integrating genetic and medical data. With this strategy, patient's digital records are transparently integrated and connected to wet-lab genetics research in a seamless working environment. The resulting knowledge base offers multiple data views, geared towards medical staff, with patient treatment and monitoring data; genetics researchers, through a custom locus-specific database; and patients, who for once play an active role in their treatment and rare diseases research.
Introduction
Biomedical research states that a rare disease is a particular condition affecting at most 1 in 2000 patients. The European Organization for Rare Diseases (EURORDIS) estimates that there are approximately 6000 to 8000 rare diseases, affecting about 6% to 8% of the population. Within these, about 80% are caused by Pedro Lopes · Rafael Mendonça · José Luís Oliveira DETI/IEETA, Universidade de Aveiro, rmendonca, jlo}@ua.pt Hugo Rocha · Jorge Oliveira · Laura Vilarinho · Rosário Santos Centro de Genética Médica Jacinto Magalhães, INSA, 4099-028 Porto, Portugal e-mail: {hugo.rocha,jorge.oliveira,laura.vilarinho, rosario.santos}@insa.min-saude.pt genetic disorders. Due to the reduced incidence of each individual disease, it is difficult for patients to find support, both at clinical and psychological level [1] . The existence of a small number of patients for each rare disease also delays the creation of adequate research studies as it is difficult to identify and coordinate a correct cohort [2, 3] . Despite the low statistic impact regarding these diseases, the combined amount of patients suffering from one of these rare diseases is considerably high. The Portuguese National Programme for Rare Disorders, approved in 2008, strives towards a concerted system for rare disease tracking and patient monitoring. This endeavor relies heavily on a platform designed to gather information from the different stakeholders involved in rare disease patient care, ranging from diagnostic labs to health providers up to policy-makers. The set of requirements behind such a large-scale project touches miscellaneous research areas. The combination of heterogeneous data from medical reports with patient records and genetic datasets triggers problems in the areas of privacy and security, service composition and data integration.
The solution we envisage relies on edge-of-breed software engineering strategies to provide a seamless working environment for everyone involved in rare disease research. The platform, a rare disease patient manager, collects and connects data for patients during their entire stay in the system. This widespread information collection, including medical reports with the initial diagnosis, patient genetic test results or the patient treatment program, is fused into a single knowledge base. From there, distinct data views are provided to distinct user roles, each accessing its own private and independent web information system. This Portuguese case study revolves around the creation of reference centres. These are more than a single physical institution, enabling the cooperation and networking amongst several public entities in the Portuguese health system and detaining a wealth of data on patients diagnosed with known rare diseases. This organizational structure, involving efforts from multidisciplinary teams, permits the best procedures to be available, simplifying processes and minimizing the resources needed. With the innovative rare disease patient manager proposed in this manuscript, the reference centres will be endowed with the required set of software tools to study the underlying rare disease causes and adverse effects and, above all, vastly improve patient care.
Overview
The importance of a patient's genetic records in diagnosis and resolution of rare diseases has taken medicine to a level where wet-lab research is crucial to unravel disease causes and consequences. Hence, databases emerging with information about human genome, such as the HGMD (Human Gene Mutation Database) [4] or the 1000 Genomes Project [5] retain growing relevance. It is important to collect their public data in novel biomedical software, enabling its usage on the daily medical workflow. Despite this growing, the absence of public medical reports, specially regarding rare disease patients, indicates the vulnerability of these patient groups [6] .
